We recently compiled a list of the Top 10 Trending AI News Updates That Investors Likely Missed. In this article, we are going to take a look at where RadNet, Inc. (NASDAQ:RDNT) stands against the other AI stocks.
Just as the AI industry was catching up with the launch of the DeepSeek AI R1 model in January, sources divulged that the Hangzhou-based company is planning to release the R2 model as early as possible. The company was previously aiming to launch the R2 model in May.
DeepSeek expects the R2 model to exhibit better coding and reasoning capabilities in multiple languages. The R1 model, which was built cost-effectively using relatively less powerful GPUs, triggered a $1 trillion sell-off in US and European markets.
The speculation around the R2 model could potentially drive further volatility in America’s AI landscape as investors question the narrative that US-based AI companies require hundreds of billions of dollars to develop AI systems.
“The launch of DeepSeek’s R2 model could be a pivotal moment in the AI industry. DeepSeek’s success at creating cost-effective AI models would likely spur companies worldwide to accelerate their own efforts … breaking the stranglehold of the few dominant players in the field.”
-said Vijayasimha Alilughatta, COO Zensar.
We selected AI stocks by reviewing news articles, stock analysis, and press releases. We listed the stocks in ascending order of their hedge fund sentiment taken from Insider Monkey’s database of over 1000 hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
A radiologist studying a monitor with a detailed image of a lung cancer tumor.
RadNet, Inc. (NASDAQ:RDNT)
Number of Hedge Fund Followers: 29
RadNet, Inc. (NASDAQ:RDNT) is a leading provider of fixed-site diagnostic imaging services in the US. The company is increasingly focusing on delivering radiology IT and AI solutions through its wholly-owned subsidiary, DeepHealth Inc., to clients in the evolving diagnostic imaging industry. DeepHealth leverages AI and its cloud-native operating system, DeepHealth OS, to boost efficiency and enhance clinical outcomes related to lung, breast, prostate, and brain health.
On February 25th, RadNet, Inc. (NASDAQ:RDNT)-owned DeepHealth Inc. announced a partnership with clinical AI and imaging advanced visualization specialist ConcertAI’s TeraRecon to integrate capabilities that will facilitate the advancement of imaging tools and radiology workflow. The goal is to develop a seamless AI-enabled diagnostic experience for imaging experts by combining TeraRecon’s advanced visualization technology with DeepHealth OS for accurate and timely diagnostic interpretations.
“At DeepHealth, we are committed to leveraging advanced AI to enhance radiology workflows, elevate the experience of care teams, and improve patient care. Partnering with TeraRecon allows us to integrate industry-leading visualization and clinical AI technology, equipping radiologists with the tools to improve efficiency and reduce variability. This collaboration strengthens DeepHealth OS, driving innovation in medical imaging.”
-said Kees Wesdorp, President and CEO of RadNet Inc.’s Digital Health division.
Overall RDNT ranks 3rd on our list of AI stocks that investors likely missed. While we acknowledge the potential of RDNT as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than RDNT but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stock To Buy Now and Complete List of All AI Companies Under $2 Billion Market Cap.
Disclosure: None. This article is originally published at Insider Monkey.